Pulmatrix announces $2.5 million registered direct offering priced at-the-market
Pulmatrix announced a securities purchase agreement with certain institutional investors, providing for the purchase and sale of 1,706,484 shares of common stock at a price of $1.465 per share in a registered direct offering priced at-the-market, resulting in gross proceeds of $2.5 million. February 08, 2019
